rts logo

Tempest Therapeutics Inc (TPST) Looks Ready for Growth Despite 15.68% Change This Year

Tempest Therapeutics Inc (NASDAQ: TPST) is 15.68% higher on its value in year-to-date trading and has touched a low of $0.17 and a high of $9.77 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TPST stock was last observed hovering at around $5.44 in the last trading session, with the day’s loss setting it -0.35%.

Currently trading at $5.09, the stock is 39.36% and 33.40% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.71 million and changing -6.43% at the moment leaves the stock 90.84% off its SMA200. TPST registered 74.91% gain for a year compared to 6-month gain of 1570.50%. The firm has a 200-day simple moving average (SMA200) of -$3.41.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The stock witnessed a 38.32% loss in the last 1 month and extending the period to 3 months gives it a 15.68%, and is 39.84% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 20.17% over the week and 12.10% over the month.

Tempest Therapeutics Inc (TPST) has around 17 employees, a market worth around $112.95M and $0.00M in sales. Distance from 52-week low is 2894.12% and -47.90% from its 52-week high. The company has generated returns on investments over the last 12 months (-69.90%).

Tempest Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -$0.37.The EPS is expected to grow by 20.37% this year.

Tempest Therapeutics Inc (TPST) Top Institutional Holders

34 institutions hold shares in Tempest Therapeutics Inc (TPST), with institutional investors hold 30.28% of the company’s shares. The shares outstanding are 22.05M, and float is at 18.44M with Short Float at 4.16%. Institutions hold 29.33% of the Float.

The top institutional shareholder in the company is EcoR1 Capital, LLC with over 1.12 million shares valued at $1.43 million. The investor’s holdings represent 8.43% of the TPST Shares outstanding. As of Jun 29, 2023, the second largest holder is FMR, LLC with 0.65 million shares valued at $0.82 million to account for 4.86% of the shares outstanding. The other top investors are Rock Springs Capital Management, LP which holds 0.54 million shares representing 4.02% and valued at over $0.68 million, while AIGH Capital Management LLC holds 3.05% of the shares totaling 0.41 million with a market value of $0.52 million.

Related Posts